About HH Biotechnology Holdings

HH Biotechnology Holdings Company, through its subsidiaries, engages in the commercial and residential real estate investment, development, sale, and/or management in the city of Shenyang, Liaoning Province, in the People’s Republic of China. The company’s subsidiaries include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. The company is focused primarily on real estate leasing, management, and consulting activities in the city of Shenyang. Building Leasing and Management Services The company’s leasing and management services were conducted in 2015 primarily with respect to real estate projects it developed in prior years. President Building comprises three blocks of commercial buildings, including two commercial towers, situated in Shenyang City, Heping North Street, which is the financial district of Shenyang. The President Building maintains its competitiveness mainly with its location at the financial center of Shenyang. The tenants as a whole are engaged in various businesses, including real estate, foreign trade, investment, insurance, e-commerce, media, advertisement, and heath care. Chenglong Garden, situated in Shenyang Huang Gu District, consist of 12 blocks of modern apartments consisting of 865 residential apartments, various retail shops and ancillary facilities, including basement car parking facilities and parks. The company leases the retail shops and related commercial space, which comprise approximately 3,198 square meters of commercial space. The Maryland Building consists of 12,858 square meters, of which 11,743 have been sold and the remaining 1,115 square meters are held for leasing purposes. History The company was incorporated in the state of Nevada in 1987. It was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016.